Celine Chui HKU
@chuiceline
Assistant Professor, School of Nursing, School of Public Health @HKUmed @hku_son @hku_sph @HKUniversity #UCLAlumni #BruinProud 🐻💙💛
ID: 1313056331251638272
https://nursing.hku.hk/people/research-faculty/sze-ling-chui 05-10-2020 10:00:05
154 Tweet
348 Followers
334 Following
Patients with COVID-19 with advanced kidney disease receiving nirmatrelvir-ritonavir had a lower rate of mortality and hospital admission when compared with molnupiravir. Prof Ian Wong Esther Chan @ CSMPR HKU zoeywong525 CSMPR_HKU HKU Pharmacy Dept. of Family Medicine and Primary Care, HKU Laboratory of Data Discovery for Health thelancet.com/journals/eclin…
Our recent paper investigating the benefits and risks of using #statins for primary prevention of #CardiovascularDiseases #CVDs and all-cause mortality in old and very old adults.Annals of Int Med doi.org/10.7326/M24-00… Wanchun (Wendy) Xu Cindy Lam Eric YF Wan #CSMPR #HKU #HKUMed
Our amazing work on a seemingly simple but important evidence in Annals of Int Med that statins work well even in old people aged ≥ 85 yrs. Thanks awesome students Wanchun (Wendy) Xu, Amanda, supervisor Cindy Lam and Harvard T.H. Chan School of Public Health collaborator Goodarz Danaei. doi.org/10.7326/M24-00…
Pre-existing heart failure is identified as a unique subphenotype associated with poor prognosis after hip fractures; congrats Dr. CL Cheung HKU Pharmacy HKU Medicine on this excellent work! rdcu.be/dJfmP
Latest paper by @CLCheung37090 team unveiling the unique clinical #phenotypes of hip #fracture patients and the temporal association with #CardiovascularEvents #CVEs Nature Communications doi.org/10.1038/s41467… HKU Pharmacy #CSMPR #HKU #HKUMed #HKUPharm #pharmacy #research
Our recent Nitin Joshi paper shows Tixagevimab–cilgavimab is effective in reducing #COVID19 infection among #immunocompromised patients. Read our target trial emulation study: doi.org/10.1007/s40264… Vincent Yan Rainee Yang Eric YF Wan HKU Pharmacy
Our study published on Nature Communications reassures the effectiveness and safety of switching from low-molecular-weight heparin #LMWH to Direct Oral Anticoagulants #DOACs among patients with cancer-associated #thromboembolism. Read the full study: doi.org/10.1038/s41467…
Proud to share Claire Cuiling WEI's first 1st-author paper FMCH Journal of The BMJ group (5-Year IF = 5.9); we are one of the first teams in the world to use #TTE and #CCW in health services research and show great value in primary care post-covid (1/3) fmch.bmj.com/content/12/3/e…
Our important study in antiviral medications for patients with COVID-19 published in The Lancet Infectious Diseases Many thanks Ivan Hung, MD FRCP (Lon,Edin) @mhchoijohn Prof Ian Wong Esther Chan @ CSMPR HKU HKU Medicine Dept. of Family Medicine and Primary Care, HKU HKU Pharmacy thelancet.com/journals/lanin…
Our another study in statin collaborating with Harvard T.H. Chan School of Public Health Yale University published in Journal of Clinical Epidemiology showed no increase risk of cancers after statin use. Many thanks Wanchun (Wendy) Xu Goodarz Danaei HKU Medicine Dept. of Family Medicine and Primary Care, HKU HKU Pharmacy jclinepi.com/article/S0895-…
My PhD extension study in 10-year risk prediction of CVD in diabetes population published in Diabetes Obesity and Metabolism. Many thanks my PhD supervisor Cindy Lam and all co-authors. HKU Medicine Dept. of Family Medicine and Primary Care, HKU HKU Pharmacy doi.org/10.1111/dom.15…
Our CARE study showed the comparative effectiveness and safety of BNT162b2 and CoronaVac published in international journal of infectious diseases. Many thanks Prof Ian Wong Esther Chan @ CSMPR HKU Boyuan Wang HKU Medicine Dept. of Family Medicine and Primary Care, HKU HKU Pharmacy Laboratory of Data Discovery for Health ijidonline.com/article/S1201-…
